These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 38408048)

  • 21. Evaluation of somatic mutations in cervicovaginal samples as a non-invasive method for the detection and molecular classification of endometrial cancer.
    Pelegrina B; Paytubi S; Marin F; Martínez JM; Carmona Á; Frias-Gomez J; Peremiquel-Trillas P; Dorca E; Zanca A; López-Querol M; Onieva I; Benavente Y; Barahona M; Fernandez-Gonzalez S; De Francisco J; Caño V; Vidal A; Pijuan L; Canet-Hermida J; Dueñas N; Brunet J; Pineda M; Matias-Guiu X; Ponce J; Bosch FX; De Sanjosé S; Alemany L; Costas L
    EBioMedicine; 2023 Aug; 94():104716. PubMed ID: 37480623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microsatellite Instability-High Endometrial Cancers with MLH1 Promoter Hypermethylation Have Distinct Molecular and Clinical Profiles.
    Manning-Geist BL; Liu YL; Devereaux KA; Paula ADC; Zhou QC; Ma W; Selenica P; Ceyhan-Birsoy O; Moukarzel LA; Hoang T; Gordhandas S; Rubinstein MM; Friedman CF; Aghajanian C; Abu-Rustum NR; Stadler ZK; Reis-Filho JS; Iasonos A; Zamarin D; Ellenson LH; Lakhman Y; Mandelker DL; Weigelt B
    Clin Cancer Res; 2022 Oct; 28(19):4302-4311. PubMed ID: 35849120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iatrogenic endometriosis harbors somatic cancer-driver mutations.
    Lac V; Verhoef L; Aguirre-Hernandez R; Nazeran TM; Tessier-Cloutier B; Praetorius T; Orr NL; Noga H; Lum A; Khattra J; Prentice LM; Co D; Köbel M; Mijatovic V; Lee AF; Pasternak J; Bleeker MC; Krämer B; Brucker SY; Kommoss F; Kommoss S; Horlings HM; Yong PJ; Huntsman DG; Anglesio MS
    Hum Reprod; 2019 Jan; 34(1):69-78. PubMed ID: 30428062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clonal relationship and directionality of progression of synchronous endometrial and ovarian carcinomas in patients with DNA mismatch repair-deficiency associated syndromes.
    Moukarzel LA; Da Cruz Paula A; Ferrando L; Hoang T; Sebastiao APM; Pareja F; Park KJ; Jungbluth AA; Capella G; Pineda M; Levin JD; Abu-Rustum NR; Ellenson LH; Bel AV; Reis-Filho JS; Matias-Guiu X; Cadoo K; Stadler ZK; Weigelt B
    Mod Pathol; 2021 May; 34(5):994-1007. PubMed ID: 33328602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicoprognostical features of endometrial cancer patients with somatic mtDNA mutations.
    Semczuk A; Lorenc A; Putowski L; Futyma K; Bryk J; Miotla P; Bartnik E
    Oncol Rep; 2006 Nov; 16(5):1041-5. PubMed ID: 17016590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma.
    Depreeuw J; Stelloo E; Osse EM; Creutzberg CL; Nout RA; Moisse M; Garcia-Dios DA; Dewaele M; Willekens K; Marine JC; Matias-Guiu X; Amant F; Lambrechts D; Bosse T
    Clin Cancer Res; 2017 Dec; 23(23):7232-7241. PubMed ID: 28939739
    [No Abstract]   [Full Text] [Related]  

  • 27. Somatic mutations of the PTEN/NMAC1 gene associated with frequent chromosomal loss detected using comparative genomic hybridization in endometrial cancer.
    Hirai Y; Tanaka N; Furuta R; Kawaguchi T; Sakamoto M; Shirahama S; Noda T
    Gynecol Oncol; 2001 Oct; 83(1):81-8. PubMed ID: 11585417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis.
    Koul A; Willén R; Bendahl PO; Nilbert M; Borg A
    Cancer; 2002 May; 94(9):2369-79. PubMed ID: 12015762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer.
    Bosse T; ter Haar NT; Seeber LM; v Diest PJ; Hes FJ; Vasen HF; Nout RA; Creutzberg CL; Morreau H; Smit VT
    Mod Pathol; 2013 Nov; 26(11):1525-35. PubMed ID: 23702729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis.
    Gibson WJ; Hoivik EA; Halle MK; Taylor-Weiner A; Cherniack AD; Berg A; Holst F; Zack TI; Werner HM; Staby KM; Rosenberg M; Stefansson IM; Kusonmano K; Chevalier A; Mauland KK; Trovik J; Krakstad C; Giannakis M; Hodis E; Woie K; Bjorge L; Vintermyr OK; Wala JA; Lawrence MS; Getz G; Carter SL; Beroukhim R; Salvesen HB
    Nat Genet; 2016 Aug; 48(8):848-55. PubMed ID: 27348297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta-analysis.
    McAlpine JN; Chiu DS; Nout RA; Church DN; Schmidt P; Lam S; Leung S; Bellone S; Wong A; Brucker SY; Lee CH; Clarke BA; Huntsman DG; Bernardini MQ; Ngeow J; Santin AD; Goodfellow P; Levine DA; Köbel M; Kommoss S; Bosse T; Gilks CB; Talhouk A
    Cancer; 2021 Jul; 127(14):2409-2422. PubMed ID: 33793971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies.
    Singh N; Piskorz AM; Bosse T; Jimenez-Linan M; Rous B; Brenton JD; Gilks CB; Köbel M
    J Pathol; 2020 Mar; 250(3):336-345. PubMed ID: 31829441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring preferred amino acid mutations in cancer genes: Applications to identify potential drug targets.
    Anoosha P; Sakthivel R; Michael Gromiha M
    Biochim Biophys Acta; 2016 Feb; 1862(2):155-65. PubMed ID: 26581171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A New Type of Endometrial Cancer Models in Mice Revealing the Functional Roles of Genetic Drivers and Exploring their Susceptibilities.
    Chen J; Dai S; Zhao L; Peng Y; Sun C; Peng H; Zhong Q; Quan Y; Li Y; Chen X; Pan X; Zhong A; Wang M; Zhang M; Yang S; Lu Y; Lian Z; Liu Y; Zhou S; Li Z; Na F; Chen C
    Adv Sci (Weinh); 2023 Aug; 10(24):e2300383. PubMed ID: 37340596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serial genomic analysis of endometrium supports the existence of histologically indistinct endometrial cancer precursors.
    Aguilar M; Zhang H; Zhang M; Cantarell B; Sahoo SS; Li HD; Cuevas IC; Lea J; Miller DS; Chen H; Zheng W; Gagan J; Lucas E; Castrillon DH
    J Pathol; 2021 May; 254(1):20-30. PubMed ID: 33506979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TP53 Mutational Spectrum in Endometrioid and Serous Endometrial Cancers.
    Schultheis AM; Martelotto LG; De Filippo MR; Piscuglio S; Ng CK; Hussein YR; Reis-Filho JS; Soslow RA; Weigelt B
    Int J Gynecol Pathol; 2016 Jul; 35(4):289-300. PubMed ID: 26556035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutational analysis of the CTNNB1 (beta-catenin) gene in human endometrial cancer: frequent mutations at codon 34 that cause nuclear accumulation.
    Ikeda T; Yoshinaga K; Semba S; Kondo E; Ohmori H; Horii A
    Oncol Rep; 2000; 7(2):323-6. PubMed ID: 10671680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TP53 mutations in endometrial cancers: relation to PTEN gene defects.
    Janiec-Jankowska A; Konopka B; Goluda C; Najmoła U
    Int J Gynecol Cancer; 2010 Feb; 20(2):196-202. PubMed ID: 20169661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a Gene Panel for Endometrioid Endometrial Cancer: a Possible Prognostic Value?
    Malentacchi F; Turrini I; Sorbi F; Projetto E; Castiglione F; Vergoni F; Amunni G; Fambrini M; Petraglia F; Noci I; Pillozzi S
    Reprod Sci; 2020 Feb; 27(2):592-598. PubMed ID: 32046431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A cost-effective, machine learning-based new unified risk-classification score (NU-CATS) for patients with endometrial cancer.
    Zheng S; Wu Y; Donnelly ED; Strauss JB
    Gynecol Oncol; 2023 Aug; 175():97-106. PubMed ID: 37336081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.